HB 2560 creates a new state-funded model to support residential pediatric recovery centers that provide nonmedical care for infants born with prenatal substance exposure (e.g., to opioids or methamphetamines) and their families. The bill requires the state to seek federal approval for direct payments to these centers by July 2027 and to provide interim grants using opioid settlement funds until then. It aims to replace lengthy hospital stays in neonatal intensive care units with a family-centered approach that promotes bonding and helps keep infants with parents in recovery. The new funding will cover services like caregiver coaching, bonding activities, and transition planning to support safe home reunification.
HB 2340 extends substance use disorder monitoring program protections to nursing assistants who are credentialed under Washington state law. It prohibits public posting of enforcement actions against these professionals if they comply with a board-approved monitoring program. The bill creates a stipend program covering up to 80% of eligible out-of-pocket costs for program participation, including treatment, evaluations, and peer support. Nursing assistants must apply for the stipend, demonstrate financial need, and actively participate in the program to qualify. The board must publicly report program participation and expenses annually.
SB 6319 requires Washington's child welfare department to create a community-based referral system for families with children under four where parental use of high-potency synthetic opioids is a factor in a child welfare case. The bill mandates that families receive referrals to substance use treatment, peer navigators, and other support services within seven days of a risk assessment, with services available for six months regardless of case status. Participation in these services must be voluntary, requiring written consent from parents or guardians. The department must develop this system by January 2027 and report on its implementation and impact by November 2027. This bill directly affects vulnerable families in child welfare cases involving opioid use, focusing on connecting them to community resources rather than altering court timelines.
HB 2437 allows Washington's Department of Health to establish fees for accrediting opioid treatment programs, which must cover the department's costs for this service. The bill directs the department to set initial and renewal fees after gaining federal approval to accredit such programs under federal rules (42 C.F.R. Part 8). These fees will be used to offset expenses, with the department permitted to draw from opioid abatement settlement funds to cover costs. The bill directly affects opioid treatment programs seeking federal accreditation and the department managing the process.
Washington State's SB 6094 creates a framework for funding specialized pediatric transitional care facilities to replace extended hospital stays for infants exposed to substances like opioids during pregnancy. The bill directly affects substance-exposed infants and their parents, aiming to support bonding and recovery by providing non-hospital care in a nurturing environment instead of neonatal intensive care units. Key provisions require the Health Care Authority to study funding models using federal/state resources, submit a report by November 2026, and provide temporary grants to a pilot facility using opioid settlement funds until the study concludes. The bill expires December 31, 2028, and focuses on concrete policy changes to reduce costs and prevent foster care placement.
SB 5933 creates a centralized system for rapidly sharing overdose data to improve public health responses. It requires Washington's Department of Health to submit near real-time data from emergency medical services (including location, opioid reversal use, and fatality status) within 24 hours of patient care reports, starting January 1, 2027. The system will help identify overdose hotspots and guide immediate interventions like outreach, public education, and treatment resources, while explicitly prohibiting the use of this data for law enforcement or individual identification. This affects ambulance services, aid providers, and the Department of Health, who must submit and manage the data under strict privacy safeguards. The bill aims to streamline collaboration across health and public safety agencies to address the opioid overdose crisis.
HB 2168 creates a real-time overdose mapping system to help prevent opioid overdoses in Washington. It requires emergency medical services (like ambulances and aid services) to submit anonymized data - such as location, time, whether reversal medication was used, and fatality status - within 24 hours of treating an overdose to a centralized program. This data helps health and public safety agencies quickly identify overdose hotspots and deploy targeted prevention efforts, like public education or treatment resources, without using the information for law enforcement. The bill explicitly prohibits using the data for criminal investigations or identifying individuals, ensuring privacy protections for those seeking care.
HB 2072 imposes a fee of $0.01 per morphine milligram equivalent on opioid manufacturers for prescription opioids dispensed in Washington. The fee funds a new "prescription opioid impact account," with 50% dedicated to behavioral health programs for children, youth, and young adults. Funds also reimburse the state for modifying the prescription monitoring program and cover administrative costs (capped at 12% annually). Manufacturers must report quarterly opioid dispensing data to the Department of Health and pay the fee within 45 days, with penalties for late payment.
HB 1362 creates a pilot program allowing courts in Washington to divert eligible individuals with gambling addiction from traditional sentencing. It requires courts to hold hearings before sentencing to determine if a crime was committed due to gambling addiction, and if so, to place the person in a treatment program supervised by mental health professionals. The program mandates restitution payments, regular progress reports, and referrals to community resources, with costs covered by the participant or through community service if they cannot pay. It excludes individuals convicted of violent crimes (like assault or domestic violence) or with prior convictions for similar offenses.
HB 2068 prohibits the sale of all flavored tobacco and nicotine products (including menthol cigarettes, flavored vapes, cigars, and hookah) and entertainment vapor products with gaming features. It increases taxes on all tobacco products to reduce youth access and addiction, directly affecting retailers who must stop selling these items and youth who use them. The bill targets products marketed with kid-friendly flavors like cotton candy or bubble gum, which the legislature cites as driving youth initiation. Key provisions include banning flavored products, raising tobacco excise taxes, and requiring retailers to verify ages for all tobacco sales.
